Nicotine E-cigarette: Clinical Trials

4 trials of Nicotine E-cigarette, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 3 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Not yet recruiting 1
Phase 31Completed 1

Follow Nicotine E-cigarette: new trials by email Literature Review of Nicotine E-cigarette trials Research Report on Nicotine E-cigarette

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiovascular Impacts of E-cigarettes Among Older Adults
Nicotine E-cigarette, Tobacco Cigarette - Hypertension, Tobacco Cigarette Smoking
Not applicableNot yet recruitingUniversity of Maryland, Baltimore402026-11-012026-10-19
Perceptions of Vaping Products
Biospecimen Collection, Survey Administration, Vaping Topography - Abuse Tobacco, Exposure
Not applicableCompletedOhio State University Comprehensive Cancer Center532025-03-032026-09-08
Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial
Nicotine E-Cigarette, Non-Nicotine E-Cigarette, Counseling - Smoking Cessation
Phase 3CompletedMcGill University3762016-11-012021-01-28
Short Term Effects of Electronic Cigarettes in Tobacco Dependent Adults
Nicotine e-cigarette, Non-nicotine e-cigarette - Smoking, Nicotine Dependence
Not applicableCompletedYale University402014-10-012017-07-02

Conditions studied

Tobacco Use Disorder (2)  ·  Vaping (2)  ·  Hypertension (1)  ·  Smoking (1)  ·  Smoking Cessation (1)

Sponsors

McGill University (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of Maryland, Baltimore (1)  ·  Yale University (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Alayna P Tackett, PhD (1)  ·  Mark J Eisenberg, MD MPH (1)  ·  Stephen R. Baldassarri, M.D. (1)

Results publications

PMID 33170240, PMID 34611902, PMID 37832989, PMID 39283667

NIH funding

R03HL188068 (1)